Urinary uracil in female patients with ornithine transcarbamylase deficiency

Pediatrics International

Volumn 47, Issue 3, 2005, Pages 262-266

  Sumi, Satoshi ^a   Imaeda, Masayuki ^a   Ito, Tetsuya ^a   Ueta, Akihito ^a   Ban, Kyoko ^a   Ohkubo, Yumiko ^a   Togari, Hajime ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Orotic acid; OTC; Uracil; Urea cycle; X inactivation

Indexed keywords

ALANINE AMINOTRANSFERASE; AMMONIA; ARGININE; ASPARTATE AMINOTRANSFERASE; GLYCYRRHIZIC ACID; ORNITHINE CARBAMOYLTRANSFERASE; OROTIC ACID; PHYTOMENADIONE; PYRIMIDINE; URACIL;

ARTICLE; CASE REPORT; DISEASE COURSE; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERAMMONEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN INTAKE; UREA CYCLE; URINALYSIS; URINARY EXCRETION; X CHROMOSOME LINKED DISORDER;

CHILD, PRESCHOOL; FEMALE; HETEROZYGOTE; HUMANS; HYPERAMMONEMIA; INFANT; ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE; OROTIC ACID; URACIL;

EID: 20444468502     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02063.x     Document Type: Article

References (15)

1. Batshaw ML, Msall M, Beaudet A, Trojak J. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency. J. Pediatr. 1986; 108: 236-41.
2. Komaki S, Matsuura T, Oyanagi K et al. Familial lethal inheritance of mutanted paternal gene in female causing X-linked ornithine transcarbamylase (OTC) deficiency. Am. J. Med. Genet. 1997; 69: 177-81.
3. Tuchman M, Morizono H, Rajagopal BS, Plante RJ, Allewell NM. The biochemical and molecular spectorum of ornithine transcarbamylase deficiency. J. Inherit. Metab. Dis. 1988; 21: 40-58.
4. McCullough BM, Yudkoff M, Batshaw ML, Wilson JM, Rager SE, Tuchman M. Genotype spectrum of ornithine transcarbamylase deficiency: Correlation with clinical and biochemical phenotype. Am. J. Med. Genet. 2000; 93: 313-19.
5. Lyon MF. X chromosome inactivation and developmental patterns in mammals. Biol. Rev. 1972; 47: 1-35.
6. Yorifuji T, Muroi J, Uematsu A et al. X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency. Clin. Genet. 1988; 54: 349-53.
7. Van Gennip AH, Van Bree-Blom EJ, Grift J, De Bree PK, Wadman SK. Urinary purine and pyrimidine in patients with hyperammonemia of various origins. Clin. Chim. Acta 1980; 104: 227-39.
8. Webster DR, Simmonds HA. Pyrimidine and purine metabolites in ornithine transcarbamylase deficiency. J. Inherit. Metab. Dis. 1981; 4: 27-31.
9. Sumi S, Matsuura T, Kidouchi K et al. Detection of ornithine transcarbamylase deficiency heterozygotes by measuring of urinary uracil. Int. J. Mol. Med. 2000; 6: 177-80.
10. Ohba S, Kidouch K, Katoh T, Kibe T, Kobayashi M, Wada Y. Automated determination of orotic acid, uracil and pseudouridine in urine by high-performance liquid chromatography with column switching. J. Chromatogr. B. 1991; 568: 325-32.
11. Kidouchi K, Nakamura C, Katoh T, Kibe T, Ohba S, Wada Y. Automated quantitave anaysis for orotidine and uridine/ thymine in urine by high-performance liquid chromatography with column switching. Adv. Exp. Med. Biol. 1991; 309B: 31-5.
12. Matuura T, Hoshide R, Setoyama C et al. Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: Application of PCR-single-strand conformation polymorphisms for all exon and adjacent introns. Hum. Genet. 1993; 92: 49-56.
13. Asai M, Sumi S, Kidouchi K et al. Urinary pyrimidine analysis on healthy newborns, infants, children, adults and patients with congenital metabolic diseases. Pediatr. Int. 2000; 42: 499-503.
14. Kubota M, Kosugiyama K, Takeda Y, Kobayashi K. Does partial ornithine transcarbamylase deficiency elict a liver dysfunction. Jpn. J. Inherit. Metab. Dis. 2003; 19: 152.
15. Valla S, Steiner F, Schlumbom V et al. Mutation of ornithine transcarbamylase (H136R) in a girl with severe intermittent orotic aciduria but normal enzyme activity. J. Inherit. Metab. Dis. 1997; 20: 517-24.